Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin- 3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3, 6-dihydropyridine-1(2H)-carboxamide (FTIDC)

Gentaroh Suzuki, Toshifumi Kimura, Akio Satow, Naoki Kaneko, Junko Fukuda, Hirohiko Hikichi, Naoko Sakai, Shunsuke Maehara, Hiroko Kawagoe-Takaki, Mikiko Hata, Tomoko Azuma, Satoru Ito, Hiroshi Kawamoto, Hisashi Ohta

Research output: Contribution to journal › Article › peer-review

67 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin- 3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3, 6-dihydropyridine-1(2H)-carboxamide (FTIDC)'. Together they form a unique fingerprint.

Medicine & Life Sciences